Genexine Market Cap

Genexine has a market cap or net worth of 216.03 billion as of June 27, 2025. Its market cap has decreased by -26.18% in one year.

Market Cap

216.03B

Enterprise Value

232.19B

Revenue

5.81B

Ranking

n/a

PE Ratio

n/a

Stock Price

4,845.00

Market Cap Chart

Since September 15, 2009, Genexine's market cap has increased from 109.02B to 216.03B, an increase of 98.16%. That is a compound annual growth rate of 4.43%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	220.35B	-9.27%
Dec 30, 2024	242.86B	-40.82%
Dec 28, 2023	410.35B	-12.73%
Dec 29, 2022	470.21B	-67.78%
Dec 30, 2021	1,459.20B	-52.47%
Dec 30, 2020	3,069.93B	106.72%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	71.46T
Celltrion	35.89T
ALTEOGEN	20.33T
Yuhan	7,706.69B
SK Biopharmaceuticals	7,150.00B
HLB Co., Ltd.	6,270.01B
Peptron	4,775.96B
PharmaResearch	4,488.33B

Market Cap Rankings